Market Size of China Patient Monitoring Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 2.47 Billion |
Market Size (2029) | USD 3.53 Billion |
CAGR (2024 - 2029) | 7.41 % |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
China Patient Monitoring Market Analysis
The China Patient Monitoring Market size is estimated at USD 2.47 billion in 2024, and is expected to reach USD 3.53 billion by 2029, growing at a CAGR of 7.41% during the forecast period (2024-2029).
The pandemic significantly impacted the patient monitoring market in China during the initial stages of the COVID-19 outbreak. As per the BMJ article published in February 2021, in China, remote health monitoring devices, mobile telecom devices, and cloud video services are used to collect and transmit information about patients in some isolation wards. The report also mentioned that wireless health monitoring equipment was used to monitor the patient's vital signs in the isolation wards in China. Thus, the usage of patient monitoring in managing COVID-19-infected patients in China during the pandemic had a crucial impact on the market growth. In addition, the demand for patient monitoring is expected to remain intact due to the rising focus on chronic diseases in patients during the post-pandemic period, fueling the market growth over the forecast period.
The increasing prevalence of chronic disease among the Chinese population, along with the rising demand for continuous monitoring, the increasing geriatric population is expected to contribute to the growth of the market. According to the NCBI article published in February 2022, asthma is a major public health challenge in China, with a national prevalence of asthma of 4.2%, representing 45.7 million Chinese adults. Such increasing prevalence of chronic disorders and various other injuries among the Chinese population is expected to drive the demand for patient monitoring owing to the effective management of these diseases, thereby fueling the market's growth.
However, the high cost of technology and stringent regulatory framework is expected to restrain the market's growth over the forecast period.